Collaborative trial of prenatal thyrotropin-releasing hormone and corticosteroids for prevention of respiratory distress syndrome

OBJECTIVE: Our purpose was to determine whether adding antenatal thyrotropin-releasing hormone to prenatal corticosteroids reduces the frequency of respiratory distress syndrome. STUDY DESIGN: A randomized, multicenter, double-blind, placebo-controlled trial was conducted of thyrotropin-releasing ho...

Full description

Saved in:
Bibliographic Details
Published in:American journal of obstetrics and gynecology 1998, Vol.178 (1), p.33-39
Main Author: Collaborative Santiago Surfactant Group
Format: Article
Language:English
Subjects:
betamethasone
Biological and medical sciences
Genital system. Reproduction
Medical sciences
neonatal mortality
Pharmacology. Drug treatments
respiratory distress syndrome
surfactant
thyrotropin-releasing hormone
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:OBJECTIVE: Our purpose was to determine whether adding antenatal thyrotropin-releasing hormone to prenatal corticosteroids reduces the frequency of respiratory distress syndrome. STUDY DESIGN: A randomized, multicenter, double-blind, placebo-controlled trial was conducted of thyrotropin-releasing hormone (400 μg intravenously every 8 hours four times) in women with singleton pregnancies
ISSN:0002-9378
1097-6868
DOI:10.1016/S0002-9378(98)70622-2